Remimazolam Besylate
YCSYY-【2025】-(J-050)
Phase 3 small_molecule active
Quick answer
Remimazolam Besylate for Critical Illness; Mechanical Ventilation; Shock is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Critical Illness; Mechanical Ventilation; Shock
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active